Skip to main content

Table 4 Studies reporting progression-related outcomes in untreated (natural history) cohorts

From: The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review

Author(s), year,

country

Number of patients with MLD

Association between GMFC-MLD at baseline and progression

Gross motor function

Cognitive function

Eating, drinking, and breathing

Key finding(s)

Artigalas et al. 2010 [9]

Brazil

22 late-infantile MLD; 4 juvenile MLD

 

  

Reports the age of acquisition and loss of neuropsychomotor developmental milestones in patients with late-infantile and juvenile MLD

Biffi et al. 2008 [76]

Italy

16 late-infantile MLD; 9 juvenile MLD

 

 

Patients with the 0/0 genotype had the most rapid decline in gross motor function and the most severe cognitive impairment. Patients with the 0/R genotype had progressive and severe motor and cognitive deficit, while patients with the R/R genotype were relatively less impaired, and cognitive function remained stable

Brown et al. 2018 [39]

USA

11 juvenile MLD

 

 

Caregivers reported impairments in physical functioning related to activities of daily living in patients with juvenile MLD

Chen et al. 2016 [42]

Australia

5 juvenile MLD in total; 2 untreateda

   

Describes age (or time after diagnosis) at which patients with juvenile MLD were gastrostomy-fed

Eichler et al. 2016 [81]

USA, France, Germany, and Colombia

14 late-infantile MLD; 6 juvenile MLD; 3 adult MLD; 30 caregivers

   

Across all clinical subtypes of MLD, 50% of caregivers reported that their dependents had difficulty swallowing, and 43% reported breathing/respiratory difficulties

Elgun et al. 2019 [45]

Germany

12 sibling pairs (3 late-infantile MLD, 9 juvenile MLD) compared with 61 unrelated children (29 late-infantile MLD, 32 juvenile MLD)

 

 

All children in the late-infantile MLD group had rapid and uniform progression of motor function decline

In the juvenile MLD group, the course of motor decline was significantly different between siblings and unrelated patients

Fumagalli et al. 2021 [49]

Italy

22 late-infantile MLD; 19 juvenile MLD (14 early-juvenile, 5 late-juvenile)

  

Significant differences in all major disease-related milestones (except death) were observed between the early-juvenile and late-juvenile MLD groups. The late-infantile MLD group displayed earlier loss of trunk control, dysphagia, and death from the time of symptom onset when compared with the early-juvenile group, but loss of ambulation and the start of seizures were similarly rapid between both groups

Groeschel et al. 2011 [51]

Germany

33 late-infantile MLD; 35 juvenile MLD

 

 

Eichler MLD MRI severity scores were significantly correlated with GMFC-MLD level in both late-infantile and juvenile MLD, but this was less remarkable in the juvenile form

Groeschel et al. 2012 [50]

Germany

18 late-infantile MLD

   

Demyelination load was associated with decline in gross motor function assessed using GMFC-MLD in patients with late-infantile MLD, and was correlated with disease duration

Groeschel et al. 2016 [52]

Germany

65 juvenile MLD (24 treated with HSCT; 41 untreated)

 

 

Ten years after disease onset, 28 of 41 patients (68%) in the untreated cohort had progressed to GMFC-MLD level 5 and had experienced loss of language, and untreated patients’ Eichler MLD MRI severity scores significantly increased from their early to late disease stagesb

Harrington et al. 2019 [53]

USA

16 late-infantile MLD; 16 juvenile MLD

 

Caregivers reported that patients with late-infantile MLD experienced rapid disease progression; mean time from first symptom to either complete loss of a gross motor function, a fine motor function, or speech was only 1.0 year (range: 0.2–4.0 years)

Jabbehdari et al. 2015 [55]

Iran

12 late-infantile MLD; 6 juvenile MLD

 

 

Patients with late-infantile MLD had difficulties with swallowing and eating 2 years after disease onset, and the mental and motor regression process lasted about 10.5 months

The progression of juvenile MLD was slower than the late-infantile form

Kehrer et al. 2011 [56]

Germany

21 late-infantile MLD; 38 juvenile MLD

  

Three-quarters of the patients with late-infantile MLD showed their first motor symptoms before the age of 18 months

The time to move from GMFC-MLD level 1 to level 6 was significantly longer in patients with juvenile MLD than in patients with late-infantile MLD

Kehrer et al. 2014 [57]

Germany

23 late-infantile MLD; 36 juvenile MLD

  

 

In the late-infantile MLD group, the median age when language decline occurred was 30 months (range: 17–42 months); almost half (48%) never learned to speak complete sentences. In the juvenile MLD group, the median age when language decline occurred was 8 years

There were significant differences between the late-infantile and juvenile MLD groups in terms of problems in concentration and behavioral problems appearing as the first symptoms of disease

Kehre et al. 2021 [5]

Germany

35 late-infantile MLD; 56 juvenile MLD (18 early-juvenile, 38 late-juvenile)

 

For all clinical endpoints, patients with cognitive onset only had significantly slower progression in the course of their disease than patients with either motor onset only or motor and cognitive onset

Patients with late-infantile MLD had significantly shorter time from disease onset to their first swallowing difficulties than patients with early-juvenile MLD; however, time from disease onset to tube feeding was similar

Kim et al. 1997 [58]

South Korea

7 late-infantile MLD

 

  

All children displayed normal development until the onset of symptoms (ranging from 9 to 28 months)

Koto et al. 2021 [16]

Japan

15 late-infantile MLD

   

Most patients (60.0%) had enteral nutrition and 20.0% had a tracheostomy; 6.7% had nasal nutrition

Liaw et al. 2015 [61]

Taiwan

5 late-infantile MLD

 

All children had rapid psychomotor regression after disease onset and became bedridden at a median age of 2 years and 5 months

The median age at which language function regressed to “unable to speak” in four patients was 2 years and 6 months, while the median age at which social function deteriorated to “loss of eye contact” in three patients was 3 years and 5 months

Of four patients who had data available on support with feeding and breathing, all had a gastric tube fitted (at ages ranging from 2.5 to 3.7 years), and one patient had home BiPAP respiratory support at the age of 5.1 years

Mahmood et al. 2010 [63]

USA

98 late-infantile MLDc; 78 juvenile MLDc

 

  

Three triplets with a diagnosis of late-infantile MLD had normal initial development; at approximately 16 months of age, a rapid change in their development was noticed

Martin et al. 2012 [104]

France

10 late-infantile MLD; 3 juvenile MLD

  

 

In the five late-infantile and three early-juvenile MLD patients with baseline and follow-up data available, changes in mean MRI severity scores over time indicated a more rapid decline in the late-infantile patients

Strolin et al. 2017 [71]

Germany

46 juvenile MLD

   

A significant positive correlation between demyelination load and higher GMFC-MLD level in patients with juvenile MLD was reported

van Rappard et al. 2016 [101]

Netherlands

8 late-infantile MLD; 18 juvenile MLD

   

Most evaluable untreated patients needed feeding via gastrostomy

van Rappard et al. 2018 [87]

Netherlands

12 juvenile MLD

   

A strong correlation between NAA concentration at baseline and GMFC-MLD score at latest follow-up was reported in untreated patients 2 years after diagnosis

Zlotogora et al. 1981 [103]

Israel

6 late-infantile MLD

 

  

Children with late-infantile MLD showed a significant delay in walking compared with unaffected children

  1. Bold text indicates that outcomes are reported separately for each clinical subtype of MLD. Ticks indicate that the study reported data for the outcome; white boxes indicate that no data were reported for the outcome
  2. BiPAP: bilevel positive airway pressure; GMFC-MLD: Gross Motor Function Classification in MLD; HSCT: hematopoietic stem cell transplantation; MLD: metachromatic leukodystrophy; MRI: magnetic resonance imaging; NAA: N-acetylaspartate; SLR: systematic literature review
  3. aUntreated patients were described as a reference or control for patients receiving treatment
  4. bKaplan–Meier survival plots for both treated and untreated patients with GMFC-MLD level < 5 and without loss of language, and Eichler MLD MRI severity scores for both treated and untreated patients are reported in Figs. 3 and 4 of the publication but were not extracted for this SLR
  5. cSLR publication